Replies to post #90544 on Biotech Values

[DewDiligence]

That formula suggests to me that MNTA and NVS have a powerful incentive not to price so aggressively that they provoke a branded-generic response.

zipjet: Do you stand by your assertions in #msg-33857504? If not, please let me know because your post is referenced in #msg-38906603, which is an entry in the MNTA ReadMeFirst :- )

p.s. You meant to say an authorized-generic response (not a branded-generic response). Authorized generics and branded generics are two entirely different things—please see #msg-42219467.